Reichert to Distribute Imaging and Dry Eye Treatment Devices in the United States
Reichert Technologies, a business of AMETEK Inc., announced an exclusive partnership with SBM Sistemi of Italy to distribute SBM’s imaging and dry eye assessment and treatment devices in the United States.
Financial terms of the deal were not disclosed.
"The collaboration with Reichert is something we have wanted to achieve for a long time, and we are proud that it has come to fruition. We believe the experience of the Reichert team is the best way to bring the SBM product line to the US market,” Michele Barberis, SBM Sistemi, President and Founder, said in a company news release.
The Reichert-SBM IDRA supports dry eye diagnosis. IDRA evaluates all the tear film layers (lipid, aqueous, and mucin) and the Meibomian glands, to identify a specific type of DED and provide personalized treatment recommendations relative to the patient’s needs. The IDRA and OS1000 ocular surface evaluation devices were designed for quick, painless, and noninvasive assessment of DED, providing accurate, reproducible and objective results, according to Reichert. The Reichert-SBM OS1000 is an integrated diagnostic platform that combines a corneal topographer with DED assessment giving eye care professionals the ability to perform various DED and topography tests all with one device, increasing operational efficiency and minimizing capital expense for practices. The Reichert-SBM DEM100-DSLC200 is an anterior imaging camera system compatible with a wide range of slit lamps and is available with comprehensive DED assessment.
The products include patient and data management software that enables eye care professionals to review images and provide diagnoses instantaneously to their patients. Customized treatment recommendations, created by a unique algorithm, are also provided to the user.
The Reichert-SBM ACTIVA is a noninvasive device that relieves symptoms caused by the Meibomian Gland Disfunction (MGD) and associated evaporative dry eye with controlled heating and micro-vibrations that stimulate the meibomian glands, increasing their functionality to provide significant and lasting symptom relief.
“The partnership with SBM Sistemi of Italy is a perfect fit for Reichert and will provide eye care practitioners and patients with unparalleled functionality and flexibility for managing dry eye disease,” said Ian Lee-Bennett, Reichert Technologies Division Vice President and Business Unit Manager. “This comprehensive family of dry eye assessment and treatment devices expands our world-leading portfolio and builds upon our wide range of trusted devices such as Phoroptor, Tono-Pen, and Ocular Response Analyzer.”